Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.OctoPlus has secured drug manufacturing contract from its existing client, which is expected to provide a boost to the company's annual revenues in 2012.
Subscribe to our email newsletter
The financial details of the contract have not been disclosed.
OctoPlus provides formulation development and clinical material manufacturing services, besides offering drug delivery technologies to develop controlled release versions of existing or new drugs.
The company manufactures Locteron, a controlled release formulation of interferon alpha to treat chronic hepatitis C, for Biolex.
Locteron’s Phase IIb clinical studies have showed superior clinical data.